Pulmonary Disease in the Immunocompromised Host, An Issue of Clinics in Chest Medicine, 1st Edition
Author :
Edited by Scott Evans, MD, Guang-Shing Cheng, MD, Julio Alberto Ramirez, M.D., F.A.C.P. and Bashar Staitieh
This item will be released on 28-03-2025
In this issue of Clinics in Chest Medicine, guest editors Drs. Scott Evans, Guang-Shing Cheng, Julio Ramirez, and Bashar Staitieh bring their considerable expertise to the topic of Pulmonary Disease in the Immunocompromised Host. Top experts discuss
...view more
In this issue of Clinics in Chest Medicine, guest editors Drs. Scott Evans, Guang-Shing Cheng, Julio Ramirez, and Bashar Staitieh bring their considerable expertise to the topic of Pulmonary Disease in the Immunocompromised Host. Top experts discuss imaging the immunocompromised lung; laboratory molecular testing in immunocompromised host pneumonia; vaccines and other preventative strategies for immunocompromised pneumonia; adjunctive/host-directed therapies in immunocompromised host pneumonia; sequelae of immunocompromised host pneumonia; and more.
In this issue of Clinics in Chest Medicine, guest editors Drs. Scott Evans, Guang-Shing Cheng, Julio Ramirez, and Bashar Staitieh bring their considerable expertise to the topic of Pulmonary Disease in the Immunocompromised Host. Top experts discuss imaging the immunocompromised lung; laboratory molecular testing in immunocompromised host pneumonia; vaccines and other preventative strategies for immunocompromised pneumonia; adjunctive/host-directed therapies in immunocompromised host pneumonia; sequelae of immunocompromised host pneumonia; and more.
Key Features
Contains 16 relevant, practice-oriented topics including COVID-19 and emerging lung infections in the immunocompromised patient; pulmonary immunocompromise in stem cell transplantation and cellular therapy; pulmonary immunocompromise in solid organ transplantation; pulmonary immunocompromise in chronic and high dose steroid therapy; and more.
Provides in-depth clinical reviews on pulmonary disease in the immunocompromised host, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Author Information
Edited by Scott Evans, MD, The University of Texas MD Anderson Cancer
Center,
Department of Pulmonary Medicine
Houston, TX, USA; Guang-Shing Cheng, MD, Clinical Research Division, Fred Hutchinson Cancer Research Center, Department of Medicine, University of Washington, Seattle, Washington, USA; Julio Alberto Ramirez, M.D., F.A.C.P., Professor of Medicine Chief, Division of Infectious
Diseases,
University of Louisville
Louisville, KY and Bashar Staitieh, Assistant Professor of Medicine, Emory University
School of Medicine
Edited by Scott Evans, MD, The University of Texas MD Anderson Cancer
Center,
Department of Pulmonary Medicine
Houston, TX, USA; Guang-Shing Cheng, MD, Clinical Research Division, Fred Hutchinson Cancer Research Center, Department of Medicine, University of Washington, Seattle, Washington, USA; Julio Alberto Ramirez, M.D., F.A.C.P., Professor of Medicine Chief, Division of Infectious
Diseases,
University of Louisville
Louisville, KY and Bashar Staitieh, Assistant Professor of Medicine, Emory University
School of Medicine
https://www.asia.elsevierhealth.com/pulmonary-disease-in-the-immunocompromised-host-an-issue-of-clinics-in-chest-medicine-9780443246487.html323584Pulmonary Disease in the Immunocompromised Host, An Issue of Clinics in Chest Medicinehttps://www.asia.elsevierhealth.com/media/catalog/product/https://www.asia.elsevierhealth.com/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.png83.29118.99USDInStock/Medicine/Respiratory Medicine /Clinics/Medicine & Surgery/Respiratory Medicine /Clinics505459550546664335123438872514886536505455341826924335088In this issue of <i>Clinics in Chest Medicine</i>, guest editors Drs. Scott Evans, Guang-Shing Cheng, Julio Ramirez, and Bashar Staitieh bring their considerable expertise to the topic of <b>Pulmonary Disease in the Immunocompromised Host</b>. Top experts discuss imaging the immunocompromised lung; laboratory molecular testing in immunocompromised host pneumonia; vaccines and other preventative strategies for immunocompromised pneumonia; adjunctive/host-directed therapies in immunocompromised host pneumonia; sequelae of immunocompromised host pneumonia; and more. In this issue of <i>Clinics in Chest Medicine</i>, guest editors Drs. Scott Evans, Guang-Shing Cheng, Julio Ramirez, and Bashar Staitieh bring their considerable expertise to the topic of <b>Pulmonary Disease in the Immunocompromised Host</b>. Top experts discuss imaging the immunocompromised lung; laboratory molecular testing in immunocompromised host pneumonia; vaccines and other preventative strategies for immunocompromised pneumonia; adjunctive/host-directed therapies in immunocompromised host pneumonia; sequelae of immunocompromised host pneumonia; and more.00add-to-cart97804432464872025ProfessionalEdited by Scott Evans, MD, Guang-Shing Cheng, MD, Julio Alberto Ramirez, M.D., F.A.C.P. and Bashar Staitieh20251Book178w x 254h (7.00" x 10.00")Elsevier240Mar 28, 2025COMING SOONEdited by <STRONG>Scott Evans</STRONG>, MD, The University of Texas MD Anderson Cancer
Center,
Department of Pulmonary Medicine
Houston, TX, USA; <STRONG>Guang-Shing Cheng</STRONG>, MD, Clinical Research Division, Fred Hutchinson Cancer Research Center, Department of Medicine, University of Washington, Seattle, Washington, USA; <STRONG>Julio Alberto Ramirez</STRONG>, M.D., F.A.C.P., Professor of Medicine Chief, Division of Infectious
Diseases,
University of Louisville
Louisville, KY and <STRONG>Bashar Staitieh</STRONG>, Assistant Professor of Medicine, Emory University
School of MedicineClinicsClinicsThe Clinics: Internal MedicineUnited StatesYesYesNoNoPlease SelectPlease SelectPlease Select
